Laure Clark

DC Office Director for @BiocomCA. Former healthcare Hill staff turned life science innovation advocate. I tweet about science, health, IP. Part French, part DC.

[Laure Clark @LaureFabrega]

@Seth_Palmer @maxpcohen It's out https://t.co/m69hE6PDrO

[Biocom @Biocom]

Thank you, @RepKevinMullin, for a productive discussion with our D.C. team and @BiocomCEO about the Bay Area’s life science ecosystem and the importance of R&D funding for startup companies. We appreciate your continued support of our industry!

[Biocom @Biocom]

We appreciate meeting with @CongressMin to discuss the impact of new federal directives on the life science industry and how we can work together to ensure that California’s innovation ecosystem and small businesses continue to thrive.

[Biocom @Biocom]

Thank you, @RepDerekTranCA, for meeting with us and our new @BiocomCEO to discuss the importance of SBIR funding. We look forward to continuing to work with you to support California’s robust life science startup companies and small businesses.

[Biocom @Biocom]

Interested in nominating your #FDA Breakthrough Device for the #TCET pathway? Manufacturers can submit formal TCET pathway nominations 12 months prior to an anticipated FDA marketing decision. Nominations for the next review cycle are due January 31. https://t.co/76IOnBawjz

[Biocom @Biocom]

Our end-of-year Public Policy Recap Report highlights our 2024 advocacy efforts that impacted members. Learn how we engaged on federal issues, secured big state legislative wins and influenced local policies supporting life science. View the report: https://t.co/DpZkw1u4QS

[Joe Panetta @Emeritus_Biocom]

Thank you @US_FDA Director Jeff Shuren for your 15 years of service leading CDRH and for your commitment to improving medical device regulatory processes. It has been an honor to work in collaboration with you all these years.

[Biocom @Biocom]

JUST RELEASED: Our 2024 Economic Impact Report in partnership with @Deloitte reveals that the life science sector in California directly provides more than 465K jobs and generates $414.2B in economic output. Access the full report here: https://t.co/488rVj6Gr7

[Biocom @Biocom]

We’ve wrapped up another successful #BiocomCAFlyIn here in Washington, D.C. Members discussed all things #emergingtech these past two days. Thank you to all the offices who took time out of their day to meet with us!

[Biocom @Biocom]

We closed out our last day of the #BiocomCAFlyIn with a meeting with @RepTedLieu. Thank you, Congressman for your leadership and support for innovation and AI policy.

[Biocom @Biocom]

Thank you to @RepKevinMullin for meeting with our #BiocomCAFlyIn participants today! It was an honor to spend time discussing matters important to our members and the biotech community with an ardent #lifescience supporter.

[Biocom @Biocom]

Thank you to the @CommerceGov for meeting with our #BiocomCAFlyIn participants today. It was great discussing @POTUS’ Executive Order on AI, a topic that is incredibly important to the industry’s development.

[Biocom @Biocom]

Our @ARPAHealth roundtable just started in San Diego with a full house of companies looking to partner and engage with this exciting new agency. Attendees are hearing directly from Director @rwegrzyn, Deputy Director, and program managers on best ways to work with the agency.

[Laure Clark @LaureFabrega]

@Allegiant Hi @Allegiant new mom traveling with an infant here. You broke my stroller today on the 1374 Boston to Sarasota flight, took no responsibility and sent me away with no solution to transporting my baby. Please contact me to replace my stroller.

[Laure Clark @LaureFabrega]

@biocom @SDbusiness @sdcivhcc @MiguelM39431348 Congrats Miguel!

[Biocom @Biocom]

Laphonza Butler was sworn in today as the new California Senator following the passing of Dianne Feinstein. Congratulations to our new Senator @LaphonzaB. Biocom California looks forward to working with you to support life science innovation in California.

[Biocom @Biocom]

Did you catch this month’s Public Policy newsletter? In it, read our mid-year policy update, our comments on CMS and EPA proposed changes, Assemblymember Robert Rivas sworn-in as California’s next speaker, and more. Subscribe at: https://t.co/YYMoZpw4iG

[Biocom @Biocom]

Grateful for the opportunity to sit down with @VitalTransform for an informative discussion on the impact of #IRA on biotech R&D in California. @BiocomCEO shares how "a well-informed and proactive approach is imperative to bring about positive change in Congress and the public."

[Biocom @Biocom]

Our 2023 federal policy priorities focus on research & pandemic preparedness, intellectual property, agriculture & energy, regulatory, drug pricing, & taxes. Learn how we work directly with legislators & regulators to drive innovation & industry success: https://t.co/AKe6i6YazR

[Biocom @Biocom]

Attention Biocom California members: Did you catch this month’s Public Policy Newsletter? Read about the release of our 2023 Economic Impact Report; CA's budget problem explained; and more. Subscribe at: https://t.co/eOx1Qdy89r